Literature DB >> 2563841

Abnormal jejunal potential difference in cystic fibrosis.

P S Baxter1, A J Wilson, N W Read, J Hardcastle, P T Hardcastle, C J Taylor.   

Abstract

Transmucosal potential difference (PD) and intraluminal pressure were recorded from the same jejunal site in 15 healthy adult controls and 4 adults with cystic fibrosis. In the controls, runs of contractions were associated with wave-like changes in PD with, during phase III-like activity, a mean peak amplitude of -9.7 mV. Although there were no obvious differences in motor patterns, wave-like changes in PD were absent in patients with cystic fibrosis. Intraluminal boluses of 4 mg pilocarpine, or 0.1 mg prostaglandin E2, caused changes of -4.6 mV and -4.5 mV, respectively, in controls; these responses were not seen in patients with cystic fibrosis. There were no significant differences in basal PD and PD changes caused by altered concentrations of infused saline or glucose between patients and controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563841     DOI: 10.1016/s0140-6736(89)91366-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Cystic fibrosis. 6. Gastrointestinal and nutritional aspects.

Authors:  H Kopelman
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

2.  Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine.

Authors:  Robert L Jakab; Anne M Collaco; Nadia A Ameen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

Review 3.  The diarrhoea of famine and severe malnutrition--is glucagon the major culprit?

Authors:  R J Levin
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 4.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

5.  Failure of cholinergic stimulation to induce a secretory response from the rectal mucosa in cystic fibrosis.

Authors:  J Hardcastle; P T Hardcastle; C J Taylor; J Goldhill
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Relationship between interdigestive motility and secretion of immunoglobulin A in human proximal small intestine.

Authors:  A Mellander; A Mattsson; A M Svennerholm; H Sjövall
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

7.  Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.

Authors:  C Högenauer; C A Santa Ana; J L Porter; M Millard; A Gelfand; R L Rosenblatt; C B Prestidge; J S Fordtran
Journal:  Am J Hum Genet       Date:  2000-10-30       Impact factor: 11.025

8.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization.

Authors:  T V Strong; K Boehm; F S Collins
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 9.  The gastrointestinal mucus system in health and disease.

Authors:  Malin E V Johansson; Henrik Sjövall; Gunnar C Hansson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-12       Impact factor: 46.802

10.  Status of fluid and electrolyte absorption in cystic fibrosis.

Authors:  M M Reddy; M Jackson Stutts
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.